<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Phase I trial of phIL12 plasmid intratumoral gene electrotransfer in patients with basal cell carcinoma in head and neck region</dc:title><dc:creator>Strojan,	Primož	(Avtor)
	</dc:creator><dc:creator>Jesenko,	Tanja	(Avtor)
	</dc:creator><dc:creator>Omerzel,	Maša	(Avtor)
	</dc:creator><dc:creator>Jamšek,	Črt	(Avtor)
	</dc:creator><dc:creator>Grošelj,	Aleš	(Avtor)
	</dc:creator><dc:creator>Lampreht Tratar,	Urša	(Avtor)
	</dc:creator><dc:creator>Markelc,	Boštjan	(Avtor)
	</dc:creator><dc:creator>Gašljević,	Gorana	(Avtor)
	</dc:creator><dc:creator>Ihan,	Alojz	(Avtor)
	</dc:creator><dc:creator>Smrekar,	Franc	(Avtor)
	</dc:creator><dc:creator>Peterka,	Matjaž	(Avtor)
	</dc:creator><dc:creator>Čemažar,	Maja	(Avtor)
	</dc:creator><dc:creator>Serša,	Gregor	(Avtor)
	</dc:creator><dc:subject>phase I clinical trial</dc:subject><dc:subject>phIL12 plasmid</dc:subject><dc:subject>interleukin-12</dc:subject><dc:subject>gene electrotransfer</dc:subject><dc:subject>basal cell carcinoma</dc:subject><dc:date>2025</dc:date><dc:date>2026-04-13 13:23:07</dc:date><dc:type>Neznano</dc:type><dc:identifier>28903</dc:identifier><dc:identifier>UDK: 616-006</dc:identifier><dc:identifier>ISSN pri članku: 1532-2157</dc:identifier><dc:identifier>DOI: 10.1016/j.ejso.2025.109574</dc:identifier><dc:identifier>COBISS_ID: 223496195</dc:identifier><dc:language>sl</dc:language></metadata>
